MarketInOut Stock Screener Log In | Sign Up

Concord Biotech Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/27/2026 15:50
Concord Biotech Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization128,558 mln
Float26.84 mln
Earnings Date10/27/2026

EPS

29.03
Exceptional

P / E

47.74
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.13
Caution advised

1-Year Forecast

1,552.60
Modest upside

Relative Strength

82 / 100
Strongly outperforming

Business Description

Founded in 1984 and headquartered in Ahmedabad, India, Concord Biotech Limited develops and manufactures specialty pharmaceutical ingredients used to treat serious conditions such as cancer, organ rejection, bacterial infections, and fungal diseases. The company serves both domestic and international markets, with a strong focus on fermentation-based production processes. It also partners with other pharmaceutical companies to provide contract research and manufacturing support.

Key Fundamentals

EPS29.03
P/E47.74
ROE14.46
RPS106
ROIC14.32
ROA12.98
Interest Cover1,202
EBITDA, mln4,366
EV / EBITDA32.80
EV / EBIT39.57
Revenue, mln11,084
EV / Revenue12.92

Quote Details

Last 1,386.00
Change 67 (5.08%)
Open 1,303.00
Volume 5,896
Turnover 8,171,856
Average Volume 7,580.71

Financial Ratios

Pre-Tax Profit Margin33
Current Ratio7.39
Price / Book7.13
Price / Tangible Book7.14
Price / Cash Flow84.82
Price / Free Cash Flow82.51
Debt / Equity0.00
Price / Sales12.96
PEG Ratio5.69

Financial Strength

Altman Z-Score42.1
Piotroski F-Score 5 / 9
Beneish M-Score-2.13
Price to Lynch Fair Value6.01
Price to Graham Number4.16
1-Year Target Price1,552.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.94% 96 / 100   
1 Month -6.17% 54 / 100   
2 Months 4.84% 76 / 100   
6 Months 37.12% 89 / 100   
1 Year -8.51% 62 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog